1. Home
  2. TREX vs TVTX Comparison

TREX vs TVTX Comparison

Compare TREX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trex Company Inc.

TREX

Trex Company Inc.

HOLD

Current Price

$38.93

Market Cap

3.7B

Sector

N/A

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$44.07

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREX
TVTX
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.8B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
TREX
TVTX
Price
$38.93
$44.07
Analyst Decision
Buy
Strong Buy
Analyst Count
17
13
Target Price
$49.53
$40.62
AVG Volume (30 Days)
1.5M
2.3M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
1.78
N/A
Revenue
$1,174,267,000.00
N/A
Revenue This Year
$5.09
$44.76
Revenue Next Year
$6.24
$35.51
P/E Ratio
$22.14
N/A
Revenue Growth
1.98
N/A
52 Week Low
$29.77
$13.88
52 Week High
$68.78
$43.31

Technical Indicators

Market Signals
Indicator
TREX
TVTX
Relative Strength Index (RSI) 45.09 71.11
Support Level $38.92 $32.62
Resistance Level $44.84 N/A
Average True Range (ATR) 1.39 1.92
MACD -0.30 0.24
Stochastic Oscillator 8.76 90.20

Price Performance

Historical Comparison
TREX
TVTX

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: